TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,402,433 | -53.2% | 646,224 | +39.2% | 0.00% | 0.0% |
| Q2 2023 | $11,532,616 | +5.0% | 464,276 | -36.4% | 0.00% | 0.0% |
| Q1 2023 | $10,987,111 | +3.5% | 730,526 | -18.6% | 0.00% | 0.0% |
| Q4 2022 | $10,612,101 | +84.1% | 897,050 | -7.9% | 0.00% | 0.0% |
| Q3 2022 | $5,764,000 | +67.1% | 973,632 | +20.0% | 0.00% | – |
| Q2 2022 | $3,450,000 | -59.7% | 811,596 | -9.9% | 0.00% | -100.0% |
| Q1 2022 | $8,565,000 | -29.1% | 900,527 | +41.7% | 0.00% | 0.0% |
| Q4 2021 | $12,077,000 | -17.8% | 635,661 | +44.0% | 0.00% | -50.0% |
| Q3 2021 | $14,696,000 | -21.8% | 441,577 | -8.8% | 0.00% | 0.0% |
| Q2 2021 | $18,784,000 | -49.9% | 484,261 | -37.8% | 0.00% | -50.0% |
| Q1 2021 | $37,500,000 | +88.2% | 778,021 | +103.1% | 0.00% | +33.3% |
| Q4 2020 | $19,923,000 | +379.0% | 382,994 | +146.4% | 0.00% | +200.0% |
| Q3 2020 | $4,159,000 | +75.9% | 155,421 | +28.1% | 0.00% | – |
| Q2 2020 | $2,364,000 | +124.1% | 121,358 | +13.2% | 0.00% | – |
| Q1 2020 | $1,055,000 | -46.2% | 107,247 | -39.4% | 0.00% | – |
| Q4 2019 | $1,962,000 | +164.1% | 176,831 | +33.7% | 0.00% | – |
| Q3 2019 | $743,000 | -57.8% | 132,240 | -34.9% | 0.00% | – |
| Q2 2019 | $1,759,000 | -47.3% | 203,268 | -51.0% | 0.00% | -100.0% |
| Q1 2019 | $3,337,000 | +5967.3% | 415,064 | +2990.6% | 0.00% | – |
| Q4 2018 | $55,000 | -99.3% | 13,430 | -99.0% | 0.00% | -100.0% |
| Q3 2018 | $7,380,000 | +452.0% | 1,317,766 | +1195.7% | 0.00% | – |
| Q2 2018 | $1,337,000 | +197.8% | 101,704 | +221.5% | 0.00% | – |
| Q1 2018 | $449,000 | +225.4% | 31,634 | +87.1% | 0.00% | – |
| Q4 2017 | $138,000 | +16.0% | 16,911 | +69.1% | 0.00% | – |
| Q3 2017 | $119,000 | +116.4% | 9,998 | +81.1% | 0.00% | – |
| Q2 2017 | $55,000 | -66.5% | 5,522 | -60.8% | 0.00% | – |
| Q1 2017 | $164,000 | +178.0% | 14,076 | +11.0% | 0.00% | – |
| Q4 2016 | $59,000 | +43.9% | 12,681 | +140.4% | 0.00% | – |
| Q3 2016 | $41,000 | -34.9% | 5,274 | -49.7% | 0.00% | – |
| Q2 2016 | $63,000 | +173.9% | 10,484 | +285.2% | 0.00% | – |
| Q1 2016 | $23,000 | +43.8% | 2,722 | +100.9% | 0.00% | – |
| Q4 2015 | $16,000 | +100.0% | 1,355 | +67.3% | 0.00% | – |
| Q3 2015 | $8,000 | -98.7% | 810 | -97.8% | 0.00% | – |
| Q2 2015 | $599,000 | +1261.4% | 36,129 | +1165.5% | 0.00% | – |
| Q1 2015 | $44,000 | +340.0% | 2,855 | +351.7% | 0.00% | – |
| Q4 2014 | $10,000 | -86.7% | 632 | -91.0% | 0.00% | – |
| Q3 2014 | $75,000 | – | 7,032 | +25944.4% | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 27 | -94.9% | 0.00% | – |
| Q4 2013 | $2,000 | -95.0% | 533 | -93.3% | 0.00% | – |
| Q3 2013 | $40,000 | -73.9% | 7,927 | -66.9% | 0.00% | – |
| Q2 2013 | $153,000 | – | 23,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |